Public Board of Directors papers 241122

Agenda item 38/22a

Meeting of the Board of Directors Thursday 24 th November 2022

Audit Committee report – October 2022

1 Introduction The Audit Committee took place on 20 th October 2022. The following summary gives the Board information on the items that were considered and any actions required by the Board. Audit Committee agenda items The items listed below were all presented to the Audit Committee for assurance. Agenda item BAF reference Assurance rating given Comments and associated action (where applicable) 2

Executive Director of Finance report

6.2

High

Key parts of the report were summarised with the following actions noted: • Confirmation to be obtained as to whether the Trust are insured against the loss of key personnel. • Report on exception list of items which don’t require a PO under the policy to be provided to ensure full visibility. • To confirm the reasoning for the 1 mandated external instruction. Updates provided on any changes since last update in April. Noted for further discussion with assurance committee chairs and exec leads as to where to place future Pharmacy updates to avoid overlap and duplication across committees. The assessment of the Trust’s self-assessment achieved substantial assurance with an overall assurance level of moderate assurance achieved. There is no required improvement plan with NHS Digital required from the 2021/22 submission and work continues to maintain and progress with the required standards for the 2022/23 submission. The external status reported for the 2021/22 DSPT submission is “Standards Met”. The medium assurance level is specifically for the achievement of the Trust’s SDMP actions. An assurance level for wider climate change goals has not been assigned as these relate to actions beyond those of the Trust.

The Christie Pharmacy Company report

6.4

High

Data Security and Protection Toolkit update

6.4

High, noting that there are actions to be delivered.

Compliance with Sustainable Development Management Plan 2021-24

8.2

Medium

13